Catalyst Wire Dossier Catalyst Wire Dossier

KOURZEQ

triamcinolone acetonide · MidAmerica Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KOURZEQ, covering 2010-07-01 to 2022-11-04. Get the full timeline:

Most recent: FDA Approved: KOURZEQ — Supplemental Application (MidAmerica Pharmaceuticals)

See pricing